[go: up one dir, main page]

DK0598365T3 - - Google Patents

Info

Publication number
DK0598365T3
DK0598365T3 DK93118411.3T DK93118411T DK0598365T3 DK 0598365 T3 DK0598365 T3 DK 0598365T3 DK 93118411 T DK93118411 T DK 93118411T DK 0598365 T3 DK0598365 T3 DK 0598365T3
Authority
DK
Denmark
Prior art keywords
weight
gamma
agent
treatment
composition
Prior art date
Application number
DK93118411.3T
Other languages
Danish (da)
Inventor
W Prof Dr Diezel
Original Assignee
Wogepharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wogepharm Gmbh filed Critical Wogepharm Gmbh
Application granted granted Critical
Publication of DK0598365T3 publication Critical patent/DK0598365T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Agent for the treatment of atopic eczema and other inflammatory skin diseases consisting of a composition for external use containing at least 0.5% by weight of gamma-linolenic acid and/or eicosapentaenoic acid and in addition 1 to 30% by weight of water-soluble magnesium salts.
DK93118411.3T 1992-11-18 1993-11-13 DK0598365T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238869A DE4238869C2 (en) 1992-11-18 1992-11-18 Agents for the treatment of atopic eczema and other inflammatory skin diseases

Publications (1)

Publication Number Publication Date
DK0598365T3 true DK0598365T3 (en) 1997-02-24

Family

ID=6473154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93118411.3T DK0598365T3 (en) 1992-11-18 1993-11-13

Country Status (4)

Country Link
EP (1) EP0598365B1 (en)
AT (1) ATE142491T1 (en)
DE (2) DE4238869C2 (en)
DK (1) DK0598365T3 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19611953A1 (en) * 1996-03-26 1997-10-02 Beiersdorf Ag Use of unsaturated monocarboxylic acids against superinfections
FR2765482B1 (en) * 1997-07-07 2000-12-08 Oreal USE OF Y-LINOLENIC ACID TO PREVENT OXIDATIVE STRESS
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
DE10347824B4 (en) * 2003-10-10 2011-08-11 Lach, Hans-Joachim, Dr., 79331 Pharmaceutical or cosmetic composition for the treatment of the skin
GB0517043D0 (en) * 2005-08-19 2005-09-28 York Pharma Plc Improvements in pharmaceutical compositions
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8673325B1 (en) * 2012-09-06 2014-03-18 Dignity Sciences Limited Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same
AU2015270418B2 (en) 2014-06-04 2020-08-06 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and use of same
MA47141A (en) 2015-05-13 2019-11-06 Ds Biopharma Ltd COMPOSITIONS CONSISTING OF 15-OXO-EPA OR 15-OXO-DGLA AND THEIR PREPARATION AND USE PROCEDURES
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
EP0432700A3 (en) * 1987-08-25 1991-06-26 Efamol Holdings Plc Use of lithium compounds for the treatment of combination skin
WO1990014824A1 (en) * 1988-01-14 1990-12-13 Anders Frithz Use of essential fatty acids for the preparation of a drug for the treatment of eczema
DK0391218T3 (en) * 1989-04-04 1996-07-29 Beiersdorf Ag Means for the prevention of atopy
DE59002748D1 (en) * 1990-01-29 1993-10-21 Wogepharm Gmbh Process for the preparation of agents for the therapy of skin diseases.
DE4042437A1 (en) * 1990-07-18 1992-06-11 Braun Melsungen Ag TOPICAL USE OF (OMEGA) -3 FATTY ACID PREPARATIONS FOR BURNS

Also Published As

Publication number Publication date
EP0598365A1 (en) 1994-05-25
DE59303744D1 (en) 1996-10-17
DE4238869C2 (en) 1994-09-08
EP0598365B1 (en) 1996-09-11
ATE142491T1 (en) 1996-09-15
DE4238869A1 (en) 1994-05-19

Similar Documents

Publication Publication Date Title
AU5150490A (en) Methods of preserving products and novel compositions therefor
FR2635263B1 (en)
DK0598365T3 (en)
GB8319073D0 (en) Fatty acid compositions
ZA935976B (en) Fatty acid treatment.
EP0222483A3 (en) Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
GR3005608T3 (en)
TW336171B (en) Pharmaceutical composition for use in the treatment of vulvar dystrophy and/or vaginal dryness
ATE258792T1 (en) HIGH LIPID DIET
SG81882A1 (en) Retinoid composition
IE881828L (en) Essential fatty acid compositions
LV10046A (en) Preparation for vascular damage prevention and treatment and use of pyridoxal glutaminate 5'-phosphate magnesium salt for vascular damage prevention and treatment
GR3026708T3 (en) Use of fatty acids for treating abnormal tissue calcification.
AU669946B2 (en) Lanolin/lanolin acid ester skin treatment composition
HK50094A (en) Skin detergent composition
TW223589B (en)
GB2208798B (en) Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
RO100495A2 (en) 10 percent solution ascorbic acid magnesium salt preparation process